sábado, 15 de diciembre de 2012

Sharp Rise in Admissions for Certain Drug Combinations

Sharp Rise in Admissions for Certain Drug Combinations


SAMHSA Headlines



Substance abuse treatment admissions for addiction involving combined use of benzodiazepine and narcotic pain relievers rose 569.7 percent to 33,701, from 2000 to 2010, according to a report by SAMHSA.
SAMHSA is seeking input and asking the public to provide feedback on the concept paper, SAMHSA's Working Definition of Trauma and Principles and Guidance for a Trauma-Informed Approach. The feedback forum will end on Friday, December 21, 2012.
"Synthetic marijuana" was linked to 11,406 of the 4.9 million drug-related emergency department visits in 2010, according to a new report by SAMHSA.
The Director of National Drug Control Policy issued a statement on December 6 regarding a new rule allowing opioid treatment programs more flexibility in dispensing buprenorphine. The rule removes restrictions on the time a patient needs to be in treatment before receiving take-home medicine.

No hay comentarios:

Publicar un comentario